Ryght's LinkedIn Live session with Simon Arkell, Co-Founder and CEO at Ryght, and Dr. Chadi Nabhan, Oncologist, Chief Medical Officer at Ryght, and author of the newly released book, The Cancer Journey: Understanding Diagnosis, Treatment, Recovery, and Prevention.
In this engaging discussion, we explore the profound insights from Dr. Nabhan's book and how they align with Ryght's mission to radically accelerate clinical trials using generative AI technology.
Discover how Ryght AI is improving cancer care by harnessing artificial intelligence to streamline manual workflows for sites and sponsors in order to accelerate clinical trials. Ryght is also building a clinical trial ecosystem that matches the best trials with the right sites, increasing trial success rates and speeding up the delivery of innovative treatments to market. Dr. Chadi Nabhan will share his extensive oncology experience, offering unique insights into the current challenges and opportunities in cancer treatment.
About Ryght
Ryght is a privately held healthcare technology company based in Anaheim, California that is developing the next generation of safe and secure generative artificial intelligence (GenAI) solutions for the biopharma industry. The Ryght platform leverages and optimizes multiple large language models (LLMs) and vector databases to ingest real-time data streams and make actionable knowledge directly available to biopharma discovery, clinical, and commercial teams. The platform enables healthcare professionals to rapidly leverage the power of GenAI within compliance of data security standards required by the industry.
Follow the company on 